IPO Boutique

Omega Therapeutics Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Omega Therapeutics Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Omega Therapeutics Inc.OMGA -
NASDAQ
$16.00-$18.00 $17.00 $22.107.4 million7/30/2021
Goldman Sachs, Jefferies, Piper Sandler
Co-Manager(s):
Wedbush PacGrow
Health Care
Filing(s):

Filed 2021-07-09
Terms Added 2021-07-26



Omega Therapeutics Inc. Quote & Chart - Click for current quote - OMGA

About Omega Therapeutics Inc. (adapted from Omega Therapeutics Inc. prospectus):
Their goal is to pioneer a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to fundamentally transform human medicine in the service of patients. Our pioneering OMEGA Epigenomic Programming platform is designed to coopt nature’s universal operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "OMGA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved